Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $2.50 billion. The enterprise value is $2.44 billion.
Market Cap | 2.50B |
Enterprise Value | 2.44B |
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 30.61 million shares outstanding. The number of shares has increased by 15.58% in one year.
Current Share Class | n/a |
Shares Outstanding | 30.61M |
Shares Change (YoY) | +15.58% |
Shares Change (QoQ) | +1.20% |
Owned by Insiders (%) | 2.76% |
Owned by Institutions (%) | 0.49% |
Float | 12.67M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 22.71 |
P/TBV Ratio | 22.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 30.73
Current Ratio | 30.73 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,419.76 |
Financial Efficiency
Return on equity (ROE) is -40.04% and return on invested capital (ROIC) is -26.89%.
Return on Equity (ROE) | -40.04% |
Return on Assets (ROA) | -25.58% |
Return on Capital (ROIC) | -26.89% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.65M |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Belite Bio has paid $5,000 in taxes.
Income Tax | 5,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +121.86% in the last 52 weeks. The beta is -1.60, so Belite Bio's price volatility has been lower than the market average.
Beta (5Y) | -1.60 |
52-Week Price Change | +121.86% |
50-Day Moving Average | 61.25 |
200-Day Moving Average | 49.39 |
Relative Strength Index (RSI) | 72.28 |
Average Volume (20 Days) | 112,307 |
Short Selling Information
Short Interest | 233,985 |
Short Previous Month | 270,587 |
Short % of Shares Out | 1.85% |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.71 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.49M |
Pretax Income | -31.62M |
Net Income | -33.03M |
EBITDA | -35.30M |
EBIT | -35.49M |
Earnings Per Share (EPS) | -$1.11 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | 112.20M |
Book Value Per Share | 3.63 |
Working Capital | 107.65M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Belite Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.58% |
Shareholder Yield | -15.58% |
Earnings Yield | -1.31% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Belite Bio is $89.00, which is 8.80% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $89.00 |
Price Target Difference | 8.80% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |